| Extension Safety and Immunogenicity Study of GPNV-001 (NCT05982314) | GPN Vaccines | 2023-07-17 |
| Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients (NCT05871333) | Ain Shams University | 2023-07-17 |
| Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial (NCT05898646) | Mayo Clinic | 2023-07-17 |
| Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone (NCT06522321) | Krishnadevaraya College of Dental Sciences & Hospital | 2023-07-15 |
| Dexmedetomidine in Topical Versus Peribulbar Anesthesia for Cataract Surgery (NCT05692167) | Kafrelsheikh University | 2023-07-15 |
| CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors (NCT05947487) | Chinese PLA General Hospital | 2023-07-15 |
| Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL (NCT05918276) | Nanfang Hospital, Southern Medical University | 2023-07-15 |
| BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma (NCT06644443) | Shenzhen University General Hospital | 2023-07-15 |
| POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy (NCT05926271) | St. Antonius Hospital | 2023-07-15 |
| CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma (NCT05948033) | Chinese PLA General Hospital | 2023-07-15 |
| Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder (NCT05692271) | Centre for Addiction and Mental Health | 2023-07-15 |
| Individualized Functional Connectivity Targeting in aiTBS for Depression (NCT05680727) | Brigham and Women's Hospital | 2023-07-15 |
| Efficacy and Safety of Empagliflozin in GSD-Ib Patients (NCT05960617) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2023-07-15 |
| Microdosing Psychedelics to Improve Mood (NCT05259943) | Rotem Petranker | 2023-07-15 |
| A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD (NCT05905133) | Connect Biopharm LLC | 2023-07-15 |
| Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas (NCT05991973) | Zhejiang University | 2023-07-15 |
| LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer (NCT05900986) | Integro Theranostics | 2023-07-14 |
| A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma (NCT05573802) | Hellenic Society of Hematology | 2023-07-14 |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT (NCT06061094) | Goethe University | 2023-07-14 |
| Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial (NCT05554341) | National Cancer Institute (NCI) | 2023-07-14 |
| A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke (NCT05953480) | Shionogi | 2023-07-14 |
| Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction (NCT05480384) | Brown University | 2023-07-14 |
| Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission (NCT05502250) | Stichting Hemato-Oncologie voor Volwassenen Nederland | 2023-07-14 |
| Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia (NCT05645718) | M.D. Anderson Cancer Center | 2023-07-14 |
| HTL0039732 in Participants With Advanced Solid Tumours (NCT05944237) | Cancer Research UK | 2023-07-13 |
| Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors (NCT05945823) | Taiho Oncology, Inc. | 2023-07-13 |
| Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms (NCT05878951) | Northwestern University | 2023-07-13 |
| AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer (NCT05904379) | Akeso | 2023-07-13 |
| A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease. (NCT05884866) | Klinikum Nürnberg | 2023-07-13 |
| IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC (NCT05994131) | InxMed (Shanghai) Co., Ltd. | 2023-07-13 |
| Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT (NCT05896007) | Ruijin Hospital | 2023-07-13 |
| Clinical Trial With Adipose Tissue Stem Cells on Biological Matrix for the Treatment of Venous Ulcer of the Lower Limbs (NCT05962931) | Andalusian Network for Design and Translation of Advanced Therapies | 2023-07-12 |
| Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF (NCT07169981) | Ain Shams University | 2023-07-12 |
| UMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHF (NCT05940545) | Liverpool School of Tropical Medicine | 2023-07-12 |
| REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 (NCT05870748) | Sutro Biopharma, Inc. | 2023-07-12 |
| Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC (NCT05414032) | University Health Network, Toronto | 2023-07-12 |
| PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis (NCT05862805) | Oregon Health and Science University | 2023-07-12 |
| Treatment of Elevated Blood Pressures in Early Pregnancy (NCT05955040) | Marshall University | 2023-07-11 |
| Optimizing Outcomes for Young Autistic Children (NCT05926687) | Northwestern University | 2023-07-11 |
| Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases (NCT05909618) | Sheba Medical Center | 2023-07-11 |
| A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma (NCT05851443) | Incyte Corporation | 2023-07-11 |
| A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer (NCT05710848) | SURGE Therapeutics | 2023-07-11 |
| Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors (NCT06005493) | AstraZeneca | 2023-07-11 |
| Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris (NCT06108193) | Chang Gung Memorial Hospital | 2023-07-11 |
| Cevostamab Following CAR T Cell Therapy for RRMM (NCT05801939) | University of Pennsylvania | 2023-07-11 |
| A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (NCT05886491) | Takeda | 2023-07-11 |
| Taurine Eye Drops May Prevent the Progression of Cataract (NCT06639711) | University Of Anbar | 2023-07-10 |
| Neuronavigation Guided iTBS With Personalized Target for Depression (NCT05577481) | Xijing Hospital | 2023-07-10 |
| Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer (NCT05571644) | Sun Yat-sen University | 2023-07-10 |
| Prevention of Traveler's Diarrhea (NCT06125626) | University of Palermo | 2023-07-10 |
| A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine (NCT06113731) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2023-07-10 |
| A Study of SHR-A1811 in Subjects With Gynaecologic Oncology (NCT05896020) | Jiangsu HengRui Medicine Co., Ltd. | 2023-07-10 |
| RCT for the Efficacy of Soothing Cream Jel in Improving Upper Limb Pain and Motion (NCT05799391) | Chinese University of Hong Kong | 2023-07-10 |
| Efficacy of Nerve Blocks for Episodic Migraine (NCT05734625) | Mayo Clinic | 2023-07-10 |
| Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP) (NCT05552755) | Recursion Pharmaceuticals Inc. | 2023-07-10 |
| Deep Brain Therapy With Low-intensity Ultrasound for Generalized Chronic Pain (NCT05674903) | University of Utah | 2023-07-10 |
| Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer (NCT05969899) | Fudan University | 2023-07-10 |
| Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma (NCT05313243) | Yale University | 2023-07-10 |
| A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations (NCT05886920) | D3 Bio (Wuxi) Co., Ltd | 2023-07-10 |
| A Study of TQB3454 Tablets in Patients With Blood Tumors (NCT06218771) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-07-10 |
| A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients (NCT05787613) | Shanghai Henlius Biotech | 2023-07-10 |
| Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT05875428) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2023-07-10 |
| A Study of Imaging in Demyelinating Diseases (NCT05805839) | Mayo Clinic | 2023-07-10 |
| A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults (NCT05972174) | ModernaTX, Inc. | 2023-07-10 |
| To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A (NCT07548411) | Gritgen Therapeutics Co., Ltd. | 2023-07-10 |
| Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 (NCT05350774) | National Institute of Neurological Disorders and Stroke (NINDS) | 2023-07-10 |
| Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia (NCT05975996) | Institute of Hematology & Blood Diseases Hospital, China | 2023-07-10 |
| Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment (NCT05957510) | Guangdong Association of Clinical Trials | 2023-07-07 |
| Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies (NCT05846659) | ImmuneSensor Therapeutics Inc. | 2023-07-07 |
| Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster (NCT05465902) | WestVac Biopharma Co., Ltd. | 2023-07-07 |
| A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. (NCT05879718) | Pfizer | 2023-07-07 |
| Terbutaline Sulfate in Adults With Asthma (NCT04973345) | Kanecia Obie Zimmerman | 2023-07-07 |
| XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC (NCT05970302) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-07-07 |
| Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia (NCT05932524) | Peking University People's Hospital | 2023-07-07 |
| Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0 (NCT05965934) | Sequana Medical N.V. | 2023-07-07 |
| Humanized Anti-CD25 Antibody for Prophylaxis of aGVHD in Elderly Underwent HID-HSCT (NCT05923814) | Institute of Hematology & Blood Diseases Hospital, China | 2023-07-07 |
| Semaglutide Therapy for Alcohol Reduction - Tulsa (NCT05891587) | Oklahoma State University Center for Health Sciences | 2023-07-07 |
| Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (NCT06434818) | Evon Medics LLC | 2023-07-07 |
| The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia (NCT05599880) | Seoul National University Hospital | 2023-07-07 |
| A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT06050226) | Wuhan Createrna Science and Technology Co., Ltd | 2023-07-06 |
| Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors (NCT05985655) | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 2023-07-06 |
| Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis (NCT05944627) | Kang Stem Biotech Co., Ltd. | 2023-07-06 |
| Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women (NCT06217354) | Cairo University | 2023-07-06 |
| A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma (NCT05256472) | Akeso | 2023-07-06 |
| Autologous Dendritic Cell Vaccine in Kidney Cancer (NCT05127824) | Jodi Maranchie | 2023-07-06 |
| A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer (NCT05966584) | Memorial Sloan Kettering Cancer Center | 2023-07-06 |
| Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult (NCT06046391) | Longbio Pharma | 2023-07-06 |
| Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics (NCT05674656) | ViiV Healthcare | 2023-07-06 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects. (NCT06147544) | PegBio Co., Ltd. | 2023-07-06 |
| Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD). (NCT06175351) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-07-06 |
| The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B (NCT05789524) | ApcinteX Ltd | 2023-07-06 |
| Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC (NCT06081582) | First Affiliated Hospital of Zhejiang University | 2023-07-06 |
| Effect of Shortwave Diathermy Versus Ultrasound Waves on Increasing ROM and Decreasing Pain After Extensor Tendon Reconstruction (NCT06113250) | Kafrelsheikh University | 2023-07-05 |
| Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma (NCT05935332) | RAPT Therapeutics, Inc. | 2023-07-05 |
| Effect of Chinese Herbal Medicine Nasal Irrigation on the Postoperative Care of Chronic Rhinosinusitis (NCT07340411) | Taichung Veterans General Hospital | 2023-07-05 |
| Study in Subjects With Mild-to-Moderate Alzheimer's Dementia (NCT05834296) | Alzamend Neuro, Inc. | 2023-07-05 |
| Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement (NCT05727176) | Taiho Oncology, Inc. | 2023-07-05 |
| Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) (NCT05451043) | AHS Cancer Control Alberta | 2023-07-05 |
| SCRT in TNT With or Without Chlorophyllin (NCT05856305) | Tata Memorial Centre | 2023-07-05 |
| Early Versus Conventional Cessation of Hydrocortisone in Septic Shock (NCT05818826) | Mahidol University | 2023-07-05 |